Capricor Therapeutics Inc (CAPR): I couldn’t resist picking up 5,000 more...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: redspinelpinktopaz post# 7971

Tuesday, 03/16/2021 2:43:53 PM

Tuesday, March 16, 2021 2:43:53 PM

I couldn’t resist picking up 5,000 more shares today.
Sarepta had a failed study for DMD and dropped 50% in 1 day.

https://www.fiercebiotech.com/biotech/sarepta-s-dmd-gene-therapy-fails-phase-2-motor-function-test-sinking-stock

Capricor had positive phase 2 results. Read the 5th paragraph of this article

https://www.globenewswire.com/news-release/2020/09/23/2098076/0/en/Capricor-Therapeutics-to-Present-Results-from-the-HOPE-2-Trial-with-CAP-1002-in-Duchenne-Muscular-Dystrophy-at-the-International-World-Muscle-Society-Virtual-Congress-2020.html

The data showed improvements in upper limb, cardiac and respiratory function, with p-values less than p=0.05 in multiple measures.

After reading above links, see this conclusion which I think underestimates Capricor but still has us as the leader:

https://kametresearch.com/dmd-duchenne-muscular-dystrophy-market-analysis/

What is holding us back is that the FDA wants a phase 3 study before approval. I believe it will be short and quickly filled. However, Dr. Marban said we do need a strategic partner to do this phase 3 study,